AstraZeneca and Oracle plan AI partnership for clinical trial recruitment
The companies aim to use real patient health data to identify potential trial participants faster, according to The Next Web. The publisher reports that they signed a non-binding term sheet, leaving the terms unfinished. The collaboration adds to other AI partnerships between pharmaceutical and technology companies.
Covered by 2 publishers within 5 hours of the first report.
Reporting2
Wall Street Journal AstraZeneca Partners With Oracle to Refine Clinical Research With AI · Adrià Calatayud
The Next Web AstraZeneca and Oracle team up on AI to find patients for drug trials · Alina Maria Stan
Related
Topics Oracle